Indivior Shares Surge 20% After Announcing $100 Million Buyback
London-listed shares of specialty pharmaceutical firm Indivior surged nearly 20% on Thursday after the company launched a $100 million share buyback and reported higher second-quarter net revenue from its opioid addiction treatment. Indivior, which...
